SCOPUS 정보 검색 플랫폼

Volumn 79, Issue 3-4, 2011, Pages 278-282

Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer

(10) Kim, Jong Gwang a Chae, Yee Soo a Sohn, Sang Kyun a Kang, Byung Woog a Moon, Joon Ho a Lee, Soo Jung a Jeon, Seong Woo a Park, Jun Seok a Park, Jin Young a Choi, Gyu Seog a

a Kyungpook National University Hospital (South Korea)

Author keywords

AKT; Colorectal cancer; mTOR; PI3K; Polymorphism; Prognosis; PTEN

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; GENOMIC DNA; MAMMALIAN TARGET OF RAPAMYCIN; OXALIPLATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON RESECTION; COLORECTAL CANCER; COLORECTAL CARCINOMA; DNA EXTRACTION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SURVIVAL RATE; TOR SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 79952602647 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000320761 Document Type: Article

Times cited : (12)

References (14)

1
- 14544300998
- Systematic review of microsatellite instability and colorectal cancer prognosis
- DOI 10.1200/JCO.2005.01.086
- Popat S, Hubner R, Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005; 23: 609-618. (Pubitemid 46224239)
- (2005) Journal of Clinical Oncology , vol.23 , Issue.3 , pp. 609-618
- Popat, S.¹ Hubner, R.² Houlston, R.S.³

2
- 40749139487
- Vascular endothelial growth factor (VEGF) gene polymorphisms associated with prognosis for patients with colorectal cancer
- Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY, Jeon SW, Lee IT, Choi GS, Jun SH: Vascular endothelial growth factor (VEGF) gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 2008; 14: 62-66.
- (2008) Clin Cancer Res , vol.14 , pp. 62-66
- Kim, J.G.¹ Chae, Y.S.² Sohn, S.K.³ Cho, Y.Y.⁴ Moon, J.H.⁵ Park, J.Y.⁶ Jeon, S.W.⁷ Lee, I.T.⁸ Choi, G.S.⁹ Jun, S.H.¹⁰

3
- 0036185848
- The protein kinase B/Akt signalling pathway in human malignancy
- DOI 10.1016/S0898-6568(01)00271-6, PII S0898656801002716
- Nicholson KM, Anderson NG: The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal 2002; 14:381-395. (Pubitemid 34214843)
- (2002) Cellular Signalling , vol.14 , Issue.5 , pp. 381-395
- Nicholson, K.M.¹ Anderson, N.G.²

4
- 23944526062
- Activation of AKT kinases in cancer: Implications for therapeutic targeting
- DOI 10.1016/S0065-230X(05)94002-5, PII S0065230X05940025
- Bellacosa A, Kumar CC, Di Cristofano A, Testa JR: Activation of AKT kinases in Cancer: implication for therapeutic targeting. Adv Cancer Res 2005; 94: 29-86. (Pubitemid 41202364)
- (2005) Advances in Cancer Research , vol.94 , Issue.1 SUPPL. , pp. 29-86
- Bellacosa, A.¹ Kumar, C.C.² Cristofano, A.D.³ Testa, J.R.⁴

5
- 0034644539
- Cell signaling by receptor ty-rosine kinases
- Schlessinger J: Cell signaling by receptor ty-rosine kinases. Cell 2000; 103: 211-225.
- (2000) Cell , vol.103 , pp. 211-225
- Schlessinger, J.¹

6
- 0032475861
- Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
- DOI 10.1016/S0092-8674(00)81780-8
- Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW: Neg-ative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998; 95:29-39. (Pubitemid 28458022)
- (1998) Cell , vol.95 , Issue.1 , pp. 29-39
- Stambolic, V.¹ Suzuki, A.² De La Pompa, J.L.³ Brothers, G.M.⁴ Mirtsos, C.⁵ Sasaki, T.⁶ Ruland, J.⁷ Penninger, J.M.⁸ Siderovski, D.P.⁹ Mak, T.W.¹⁰

7
- 34548683699
- Activation of the serine/threonine protein kinase Akt during the progression of Barrett neoplasia
- DOI 10.1016/j.humpath.2007.03.003, PII S0046817707001293
- Sagatys E, Garrett CR, Boulware D, Kelley S, Malafa M, Cheng JQ, Sebti S, Coppola D: Ac-tivation of the serine/threonine protein ki-nase Akt during the progression of Barrett neoplasia. Hum Pathol 2007; 38: 1526-1531. (Pubitemid 47418964)
- (2007) Human Pathology , vol.38 , Issue.10 , pp. 1526-1531
- Sagatys, E.¹ Garrett, C.R.² Boulware, D.³ Kelley, S.⁴ Malafa, M.⁵ Cheng, J.Q.⁶ Sebti, S.⁷ Coppola, D.⁸

8
- 66249116702
- PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mu-tant cancers
- Wee S, Jagani Z, Xiang KX, Loo A, Dorsch M, Yao YM, Sellers WR, Lengauer C, Steg-meier F: PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mu-tant cancers. Cancer Res 2009; 69:4286-4293.
- (2009) Cancer Res , vol.69 , pp. 4286-4293
- Wee, S.¹ Jagani, Z.² Xiang, K.X.³ Loo, A.⁴ Dorsch, M.⁵ Yao, Y.M.⁶ Sellers, W.R.⁷ Lengauer, C.⁸ Stegmeier, F.⁹

9
- 0003443709
- Lyon, IARC Press
- Hamilton SR, Aaltonen LA: WHO Classifi-cation. Tumours of the Digestive System: Pa-thology and Genetics. Lyon, IARC Press, 2000.
- (2000) WHO Classifi-cation. Tumours of the Digestive System: Pa-thology and Genetics
- Hamilton, S.R.¹ Aaltonen, L.A.²

10
- 0003809054
- New York, Springer
- Greene FL, Page DL, Fleming ID: The AJCC Cancer Staging Manual, ed 6. New York, Springer, 2002.
- (2002) The AJCC Cancer Staging Manual, Ed 6
- Greene, F.L.¹ Page, D.L.² Fleming, I.D.³

11
- 27644439141
- Efficiency and power in genetic association studies
- DOI 10.1038/ng1669, PII N1669
- de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-1223. (Pubitemid 41568704)
- (2005) Nature Genetics , vol.37 , Issue.11 , pp. 1217-1223
- De Bakker, P.I.W.¹ Yelensky, R.² Pe'Er, I.³ Gabriel, S.B.⁴ Daly, M.J.⁵ Altshuler, D.⁶

12
- 0036632368
- The phosphati-dylinositol 3-Kinase AKT pathway in hu-man cancer
- Vivanco I, Sawyers CL: The phosphati-dylinositol 3-Kinase AKT pathway in hu-man cancer. Nat Rev Cancer 2002; 2: 489-501.
- (2002) Nat Rev Cancer , vol.2 , pp. 489-501
- Vivanco, I.¹ Sawyers, C.L.²

13
- 73949109246
- Genetic variation in PI3K-AKT-mTOR pathway and bladder cancer risk
- Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, Hildebrandt MA, Lin J, Ye Y, Chamberlain RM, Dinney CP, Wu X: Genet-ic variation in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis 2009; 30:2047-2052.
- (2009) Carcinogenesis , vol.30 , pp. 2047-2052
- Chen, M.¹ Cassidy, A.² Gu, J.³ Delclos, G.L.⁴ Zhen, F.⁵ Yang, H.⁶ Hildebrandt, M.A.⁷ Lin, J.⁸ Ye, Y.⁹ Chamberlain, R.M.¹⁰ Dinney, C.P.¹¹ Wu, X.¹²

14
- 60849109531
- Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical out-comes in esophageal cancer patients treated with chemoradiotherapy
- Hildebrandt MA, Yang H, Hung MC, Izzo JG, Huang M, Lin J, Ajani JA, Wu X: Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical out-comes in esophageal cancer patients treated with chemoradiotherapy. J Clin Oncol 2009; 27:857-871.
- (2009) J Clin Oncol , vol.27 , pp. 857-871
- Hildebrandt, M.A.¹ Yang, H.² Hung, M.C.³ Izzo, J.G.⁴ Huang, M.⁵ Lin, J.⁶ Ajani, J.A.⁷ Wu, X.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.